- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 14 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 10 residues within 4Å:- Chain A: S.407, S.468, C.469, S.479, K.480, C.499, N.501, S.503, Y.524, D.526
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.524
- Hydrogen bonds: A:C.469, A:S.479, A:N.501, A:D.526
- Water bridges: A:K.480
NAG.6: 8 residues within 4Å:- Chain A: S.537, M.566, N.568, F.569, K.571, N.572, T.590, S.591
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:K.571
- Hydrogen bonds: A:S.537, A:N.568
NAG.7: 4 residues within 4Å:- Chain A: R.674, R.695, N.698, R.701
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:R.674
- Hydrogen bonds: A:R.695, A:N.698, A:R.701, A:R.701
- Water bridges: A:R.674
NAG.8: 4 residues within 4Å:- Chain A: N.391, S.393, K.396, H.493
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.391, A:K.396
NAG.9: 3 residues within 4Å:- Chain A: F.485, N.512, S.514
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.512, A:N.512
NAG.10: 4 residues within 4Å:- Chain A: K.306, G.309, D.310, N.339
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:G.309, A:N.339
- Water bridges: A:R.335, A:N.339
NAG.11: 7 residues within 4Å:- Chain A: E.632, L.633, D.634, N.657, S.659, T.681, N.705
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.633, A:N.657
NAG.13: 10 residues within 4Å:- Chain B: S.407, S.468, C.469, S.479, K.480, C.499, N.501, S.503, Y.524, D.526
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:Y.524
- Hydrogen bonds: B:C.469, B:S.479, B:N.501, B:D.526, B:D.526
NAG.14: 9 residues within 4Å:- Chain B: S.537, M.566, N.568, F.569, K.571, N.572, T.590, S.591
- Ligands: SO4.23
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:K.571
- Hydrogen bonds: B:S.537, B:N.568, B:K.571
NAG.15: 4 residues within 4Å:- Chain B: F.485, N.512, S.514, T.538
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.512, B:N.512
- Water bridges: B:E.515
NAG.16: 5 residues within 4Å:- Chain B: N.391, S.393, M.394, K.396, H.493
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.391, B:K.396
NAG.17: 4 residues within 4Å:- Chain B: K.306, G.309, D.310, N.339
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:G.309, B:N.339
- Water bridges: B:R.335, B:N.339
NAG.18: 5 residues within 4Å:- Chain B: E.631, E.632, N.657, T.681, N.705
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.631, B:E.631, B:T.681
- Water bridges: B:N.657, B:N.657
NAG.19: 3 residues within 4Å:- Chain B: E.671, R.674, N.698
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.671, B:E.671, B:R.674, B:N.698
- 2 x QEC: N~7~-butyl-2-({4-[(cyclobutylamino)methyl]-2-methoxyphenyl}methyl)-2H-pyrazolo[4,3-d]pyrimidine-5,7-diamine(Non-covalent)
QEC.12: 20 residues within 4Å:- Chain A: T.510, D.533, L.535, H.536, Y.557, G.562, I.563, T.564
- Chain B: Y.242, N.243, F.327, F.329, Q.332, V.333, Y.334, G.357, V.359, T.384, F.386, K.410
17 PLIP interactions:11 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:F.327, B:F.329, B:Y.334, B:Y.334, B:V.359, B:F.386, A:L.535
- Hydrogen bonds: B:Q.332, A:T.564, A:T.564, A:T.564
- Water bridges: B:Y.242, B:Y.242, A:D.533
- pi-Stacking: B:F.386, B:F.386
- Salt bridges: A:D.533
QEC.20: 19 residues within 4Å:- Chain A: Y.242, N.243, F.327, F.329, Q.332, V.333, Y.334, G.357, V.359, K.361, T.384, F.386
- Chain B: T.510, D.533, L.535, H.536, G.562, I.563, T.564
15 PLIP interactions:9 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:F.327, A:F.329, A:Y.334, A:Y.334, A:V.359, A:F.386, B:L.535
- Hydrogen bonds: A:Q.332, B:T.564, B:T.564, B:T.564
- pi-Stacking: A:F.386, A:F.386
- Water bridges: B:D.533
- Salt bridges: B:D.533
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.21: 7 residues within 4Å:- Chain A: N.243, A.244
- Chain B: S.589, T.590, R.592, R.619, Y.620
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.592, B:Y.620, A:N.243, A:A.244
- Water bridges: B:S.589, B:T.590, B:R.619
- Salt bridges: B:R.619
SO4.22: 4 residues within 4Å:- Chain B: N.568, S.591, R.592, T.593
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.592, B:T.593, B:T.593
- Water bridges: B:N.568, B:N.568
SO4.23: 5 residues within 4Å:- Chain B: H.536, S.537, T.538, M.566
- Ligands: NAG.14
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.537, B:S.537
- Water bridges: B:H.536, B:T.538
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Poudel, Y.B. et al., Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-02-07
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 14 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x QEC: N~7~-butyl-2-({4-[(cyclobutylamino)methyl]-2-methoxyphenyl}methyl)-2H-pyrazolo[4,3-d]pyrimidine-5,7-diamine(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Poudel, Y.B. et al., Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-02-07
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B